Search Results - "Marzotti, S"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse by CALCINARO, F, DIONISI, S, DE SIMONE, C, DI MARIO, U, FALORNI, A, BOIRIVANT, M, DOTTA, F, MARINARO, M, CANDELORO, P, BONATO, V, MARZOTTI, S, CORNELI, R. B, FERRETTI, E, GULINO, A, GRASSO, F

    Published in Diabetologia (01-08-2005)
    “…Recent observations suggest the involvement of the gastrointestinal tract in the pathogenesis of islet autoimmunity. Thus, the modulation of gut-associated…”
    Get full text
    Journal Article
  2. 2

    Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study by Lucidi, P, Porcellati, F, Candeloro, P, Cioli, P, Marinelli Andreoli, A, Marzotti, S, Schmidt, R, Bolli, G.B, Fanelli, C.G

    “…Abstract Background and aims After subcutaneous injection insulin glargine is rapidly metabolized to M1 and M2. In vitro , both M1 and M2 have metabolic…”
    Get full text
    Journal Article
  3. 3

    Metabolic and cardiovascular profile in patients with Addison’s disease under conventional glucocorticoid replacement by Giordano, R., Marzotti, S., Balbo, M., Romagnoli, S., Marinazzo, E., Berardelli, R., Migliaretti, G., Benso, A., Falorni, A., Ghigo, E., Arvat, E.

    Published in Journal of endocrinological investigation (01-12-2009)
    “…Objective : Although two studies have shown that Addison’s disease (AD) is still a potentially lethal condition for cardiovascular, malignant, and infectious…”
    Get full text
    Journal Article
  4. 4

    Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes by Bolli, G.B, Luzio, S, Marzotti, S, Porcellati, F, Sert-Langeron, C, Charbonnel, B, Zair, Y, Owens, D.R

    Published in Diabetes, obesity & metabolism (01-03-2011)
    “…Aims: A multinational, randomized, double-blind, two-way crossover trial to compare the pharmacokinetic and pharmacodynamic properties of bolus, subcutaneously…”
    Get full text
    Journal Article
  5. 5

    Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia by Porcellati, F, Pampanelli, S, Rossetti, P, Busciantella Ricci, N, Marzotti, S, Lucidi, P, Santeusanio, F, Bolli, G. B, Fanelli, C. G

    Published in Diabetologia (01-02-2007)
    “…Aims/hypothesis The aim of our study was to establish whether the well-known defective or absent secretion of glucagon in type 1 diabetes in response to…”
    Get full text
    Journal Article
  6. 6

    Blood cell mitochondrial DNA content and premature ovarian aging by Bonomi, Marco, Somigliana, Edgardo, Cacciatore, Chiara, Busnelli, Marta, Rossetti, Raffaella, Bonetti, Silvia, Paffoni, Alessio, Mari, Daniela, Ragni, Guido, Persani, Luca

    Published in PloS one (03-08-2012)
    “…Primary ovarian insufficiency (POI) is a critical fertility defect characterized by an anticipated and silent impairment of the follicular reserve, but its…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Counterregulatory Hormone and Symptom Responses to Insulin-Induced Hypoglycemia in the Postprandial State in Humans by PORCELLATI, Francesca, PAMPANELLI, Simone, ROSSETTI, Paolo, CORDONI, Cristina, MARZOTTI, Stefania, SCIONTI, Luciano, BOLLI, Geremia B, FANELLI, Carmine G

    Published in Diabetes (New York, N.Y.) (01-11-2003)
    “…Counterregulatory Hormone and Symptom Responses to Insulin-Induced Hypoglycemia in the Postprandial State in Humans Francesca Porcellati , Simone Pampanelli ,…”
    Get full text
    Journal Article